FDA approves Monsanto drug for arthritis
Life sciences firm Monsanto Co. said on Thursday the US Food and Drug Administration approved its drug Celebrex to treat rheumatoid arthritis and osteoarthritis, putting Monsanto first in line to
Life sciences firm Monsanto Co. said on Thursday the US Food and Drug Administration approved its drug Celebrex to treat rheumatoid arthritis and osteoarthritis, putting Monsanto first in line to